直击进博会|“组团打擂”进博会“买买买” 多省市抢抓招商引资机遇

Group 1 - The eighth China International Import Expo (CIIE) is being held from November 5 to 10 at the National Exhibition and Convention Center in Shanghai, with over 500 participants from the Jiading District's investment promotion team engaging in targeted招商活动 [1] - As of November 7, the Jiading District team has connected with 377 enterprises, establishing deep ties with quality companies such as Polylactide Technology, AOS (China), and Medtronic [1] - The Zhejiang trading group signed 24 import procurement agreements with suppliers from 14 countries, covering advanced equipment, energy resources, and agricultural products, with a total contract value of approximately 14.5 billion yuan [1] Group 2 - Dian Diagnostics, a participant in the Zhejiang trading group, signed a procurement contract with Roche Diagnostics for laboratory reagent consumables and is focusing on AI-assisted diagnostic fields [2] - The Jiangsu provincial state-owned enterprise Suhao Holdings signed a strategic cooperation agreement with Mitsubishi Heavy Industries for central air conditioning products, with a procurement amount of 50 million USD [2][3] - The Yangpu trading group in Shanghai signed contracts covering consumer goods, food, art, new materials, and medical devices, with a significant increase in intended transaction amounts [3] Group 3 - The "China-Central Asia Trade Smooth Cooperation Platform Promotion Conference" was held, where Kazakhstan's Akmolinsk region signed an investment development center agreement with Jiangsu Province [5] - The Jiading District's investment promotion event showcased its automotive industry, reporting a total automotive output exceeding 490 billion yuan and over 1,240 industry chain enterprises [6] - The Pudong New Area's Lin-gang New Area signed a strategic cooperation agreement with Beijing's Changping District, focusing on cross-border and international resource integration [6][7] Group 4 - Ningbo City in Zhejiang Province hosted a roundtable for multinational corporate executives, resulting in four investment cooperation intentions in AI, health care, and biomedicine [7]